The Scientist

» quality control

Most Recent

image: Stem Cells Off the Line

Stem Cells Off the Line

By | April 1, 2014

Researchers work to improve the efficiency of cell therapy manufacturing, while developing procedures to ensure consistent quality.      

0 Comments

image: Bogus Isomer Vendors Identified

Bogus Isomer Vendors Identified

By | May 25, 2012

Pharma company publishes a list of 17 companies known to have sold the incorrect isomer of the kinase inhibitor bosutinib.

3 Comments

image: Mismarketed Chemical Causes Concern

Mismarketed Chemical Causes Concern

By | May 13, 2012

An incorrect isomer of the kinase inhibitor bosutinib is circulating in the biomedical research community, potentially throwing doubt on study results.

4 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham